Abstract: The invention relates to iron(III) complex compounds and pharmaceutical compositions comprising them for the use as medicaments, in particular for the treatment and/or prophylaxis of iron deficiency symptoms and iron deficiency anemias.

Abstract: A method and system of setting up a data link between medical appliances (M1-M6) and a computer system (1) in which for each of the medical appliances (M1-M6) at least one communication protocol (P1-P6) is stored together with the communication parameters (K1a, K1b, K1c . . . -K6a, K6b, K6c . . . ) assigned to this communication protocol (P1-P6). The method comprises the following steps: setting communication parameters (K1a, K1b, K1c . . . -K6a, K6b, K6c . . . ) of a communication protocol (P1-P6); receiving data from a medical appliance (M1-M6); checking whether the data received from the medical appliance (M1-M6) correspond to sample data which are characteristic for the communication protocol (P1-P6); repetition of steps a. to c. with other communication parameters (K1a, K1b, K1c . . . -K6a, K6b, K6c . . .

Abstract: The invention relates to a process for preparing binders which contain 1) allophanate groups, 2) groups that react with ethylenically unsaturated compounds with polymerization on exposure to actinic radiation (radiation-curing groups) and 3) optionally NCO-reactive groups, by reacting at temperatures ?130° C. A) one or more NCO-functional compounds containing uretdione groups with B) one or more compounds that contain isocyanate-reactive groups and groups that react with ethylenically unsaturated compounds with polymerization on exposure to actinic radiation (radiation-curing groups), and then C) with one or more saturated, hydroxyl-containing compounds other than B), at least one of these compounds having an OH functionality of ?2, in the presence of D) a catalyst containing one or more ammonium salts or phosphonium salts of aliphatic or cycloaliphatic carboxylic acids, the reaction with compounds C) taking place at least proportionally with the formation of allophanate groups.

Abstract: A method and system of setting up a data link between medical appliances (M1-M6) and a computer system (1) in which for each of the medical appliances (M1-M6) at least one communication protocol (P1-P6) is stored together with the communication parameters (K1a, K1b, K1c . . . -K6a, K6b, K6c . . . ) assigned to this communication protocol (P1-P6). The method comprises the following steps: setting communication parameters (K1a, K1b, K1c . . . -K6a, K6b, K6c . . . ) of a communication protocol (P1-P6); receiving data from a medical appliance (M1-M6); checking whether the data received from the medical appliance (M1-M6) correspond to sample data which are characteristic for the communication protocol (P1-P6); repetition of steps a. to c. with other communication parameters (K1a, K1b, K1c . . . -K6a, K6b, K6c . . .

Abstract: The present invention provides a catalyst containing titanium in bonded form, non-crystalline silicon dioxide and at least one crystalline silicate phase which has a zeolite structure, wherein the non-crystalline silicon dioxide is applied to at least one of the crystalline silicate phases which have a zeolite structure and wherein at least one of the crystalline silicate phases which have a zeolite structure contains silicon-carbon bonds with which non-hydrolytically separable organic groups R are bonded to silicon. Furthermore, the present invention provides a process for preparing this catalyst and a process for producing an epoxide from a compound which contains a carbon-carbon double bond (preferably from propene) comprising reacting the compound which contains a carbon-carbon double bond with hydrogen peroxide in the presence of the catalyst according to the invention.

Abstract: The present invention provides hydro-oxidation catalysts for the oxidation of hydrocarbons, containing an organic-inorganic hybrid material as well as gold particles and/or silver particles, a process for the production thereof, and the use thereof as a catalyst.

Abstract: There is a method for the mechanical disintegration of biogenic sewage sludge, for which the sewage sludge, in an initial state, has microorganisms in the form of cells and a solid, which is formed essentially from aggregates of cells and suspended materials, and for which a disintegration process (3, 4) causes a destruction of aggregates and a destruction of cells. It is desirable to improve the disintegration. This is achieved in that, in a first disintegration step 3, primary destruction of aggregates and, in a subsequent, separate second disintegration step 4, primary destruction of cells is caused. Due to the use of two separate disintegration processes, an appreciable improvement in the disintegration is achieved, since fewer aggregates and more cells are supplied to the second disintegration process. The increased destruction of cells brings about the improvement in the disintegration.

Abstract: Compounds of the formula I cyclo-(aArg-aGly-aAsp-aX-aY)  I in which aArg, aGly, aAsp, aX and aY have the meanings indicated in claim 1, and their salts, can be used as integrin inhibitors, in particular for the prophylaxis and treatment of diseases of the circulation, in thrombosis, cardiac infarct, coronary heart diseases, arteriosclerosis, in pathological processes which are supported or propagated by angiogenesis and in tumour therapy.